
Outdated BRCA tests and age limits may miss thousands of cancer risks
Older genetic tests may have missed cancer-linked mutations, and new research suggests age-based testing limits exclude most patients with hereditary risks.
All articles tagged with #brca

Older genetic tests may have missed cancer-linked mutations, and new research suggests age-based testing limits exclude most patients with hereditary risks.

A new wave of medical guidance and clinical trials is pushing for wider adoption of risk-reducing salpingectomy, a procedure that removes fallopian tubes to prevent ovarian cancer. While evidence suggests this surgery can cut cancer risk by nearly 80%, it remains underutilized due to a lack of routine clinical counseling and patient awareness. Recent updates from the American College of Obstetricians and Gynecologists (ACOG) and new trials like the SOROCk study aim to bridge this gap by offering alternatives to immediate surgical menopause.

A person undergoing cancer treatment considers whether to inform family members about their potential genetic risk for cancer, opting to share general family history information without specific details about BRCA mutations to avoid causing panic, and seeks advice on the appropriateness of this approach.

Genetic testing can detect changes in genes that increase the risk of certain cancers, such as breast, ovarian, and colorectal cancers. Individuals with a family history of cancer or who have been diagnosed with cancer at a young age may consider genetic testing. Positive test results may cause stress and ethical issues, so consulting with a genetic counselor is recommended. For those with mutations in genes such as BRCA1, BRCA2, or Lynch syndrome, early screening and preventative measures can help detect or lower the risk of developing cancer.